Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-218 and miR-129 regulate breast cancer progression by targeting Lamins
Stephanie Rebecca Setijono, Mi‐Kyung Park, Goeun Kim, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 496, Iss. 3, pp. 826-833
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis
Mi Kyung Park, Li Zhang, Kyung‐Won Min, et al.
Cell Metabolism (2021) Vol. 33, Iss. 12, pp. 2380-2397.e9
Open Access | Times Cited: 134
MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer
Sanna Khan, Humaira Ayub, Taous Khan, et al.
Biochimie (2019) Vol. 167, pp. 12-24
Closed Access | Times Cited: 85
<p>Resistance and Overcoming Resistance in Breast Cancer</p>
Andrea Luque-Bolivar, Erika Pérez-Mora, Victoria Eugenia Villegas, et al.
Breast Cancer Targets and Therapy (2020) Vol. Volume 12, pp. 211-229
Open Access | Times Cited: 74
Ovarian cancer: epigenetics, drug resistance, and progression
Weiwei Xie, Huizhen Sun, Xiaoduan Li, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 64
miR-218-5p and doxorubicin combination enhances anticancer activity in breast cancer cells through Parkin-dependent mitophagy inhibition
Francesco Naso, Krenare Bruqi, Valeria Manzini, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling
Chunyong Han, Xuebiao Li, Qian Fan, et al.
Aging (2019) Vol. 11, Iss. 14, pp. 4858-4875
Open Access | Times Cited: 64
Mechanism and role of nuclear laminin B1 in cell senescence and malignant tumors
Tingcong Lv, Cong Wang, Jialin Zhou, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets
Tomasz Sirek, Katarzyna Król-Jatręga, Przemysław Borawski, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression
Marek Samec, Alena Líšková, Peter Kubatka, et al.
Journal of Cancer Research and Clinical Oncology (2019) Vol. 145, Iss. 7, pp. 1665-1679
Closed Access | Times Cited: 47
LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma
Shian Liao, Shuxing Xing, Yanhui Ma
Cancer Chemotherapy and Pharmacology (2019) Vol. 83, Iss. 6, pp. 1065-1074
Closed Access | Times Cited: 38
Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial–mesenchymal transition and angiogenesis in triple-negative breast cancer cells
Samaneh Shojaei, Maryam Moradi‐Chaleshtori, Mahdi Paryan, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 10
Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation
Franz-Josef Wischmann, Fabian M. Troschel, Maj Frankenberg, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8455-8465
Open Access | Times Cited: 9
Multi-omics analyses provide novel biological insights to distinguish lobular ductal types of invasive breast cancers
Ambily Sivadas, Victor C. Kok, Ka‐Lok Ng
Breast Cancer Research and Treatment (2022) Vol. 193, Iss. 2, pp. 361-379
Closed Access | Times Cited: 15
Up-regulation of miR-381 inhibits NAD+ salvage pathway and promotes apoptosis in breast cancer cells.
Zahra Bolandghamat Pour, Mitra Nourbakhsh, Kazem Mousavizadeh‬, et al.
PubMed (2019) Vol. 18, pp. 683-696
Closed Access | Times Cited: 24
MiR-4295 facilitates cell proliferation and metastasis in head and neck squamous cell carcinoma by targeting NPTX1
Shun Lu, Cheng Zhou, Bingwen Zou, et al.
Genes and Immunity (2019) Vol. 21, Iss. 1, pp. 4-12
Closed Access | Times Cited: 22
PCAT‐1 promotes cell growth by sponging miR‐129 via MAP3K7/NF‐κB pathway in multiple myeloma
Xianjuan Shen, Shan Kong, Qian Yang, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 6, pp. 3492-3503
Open Access | Times Cited: 21
Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
Jun Sheng Wong, Yoke Kqueen Cheah
Non-Coding RNA (2020) Vol. 6, Iss. 3, pp. 29-29
Open Access | Times Cited: 18
Targeted delivery of miR-218 via decorated hyperbranched polyamidoamine for liver cancer regression
Asmaa M. Elfiky, Rania Hassan Mohamed, Fatma El-Zahraa Abd El-Hakam, et al.
International Journal of Pharmaceutics (2021) Vol. 610, pp. 121256-121256
Closed Access | Times Cited: 16
Role of lamins in cellular physiology and cancer
Ravi Chauhan, Ashna Gupta, Gunjan Dagar, et al.
Advances in protein chemistry and structural biology (2024), pp. 119-153
Closed Access | Times Cited: 1
Advances in research on the relationship between the LMNA gene and human diseases (Review)
Jiumei Zhao, Huijuan Zhang, Chenglong Pan, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 6
Open Access | Times Cited: 1
LincRNAs and snoRNAs in Breast Cancer Cell Metastasis: The Unknown Players
Maria Louca, Vasiliki Gkretsi
Cancers (2022) Vol. 14, Iss. 18, pp. 4528-4528
Open Access | Times Cited: 8
Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power
James S. Brown
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105206-105206
Closed Access | Times Cited: 4
MiR-129-5p/TRIP13 affects malignant phenotypes of colorectal cancer cells.
Yongqing Cao, Fang Huang, Jiheng Liu, et al.
PubMed (2022) Vol. 37, Iss. 9, pp. 879-888
Closed Access | Times Cited: 7
<em>MALAT1 </em>promotes proliferation, migration, and invasion of MG63 cells by upregulation of <em>TGIF2 </em>via negatively regulating <em>miR-129</em>
Kai Liu, Yingang Zhang, Liang Liu, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 8729-8740
Open Access | Times Cited: 11
Comprehensive Analysis of the Prognostic Significance of Hsa-miR-100-5p and Its Related Gene Signature in Stomach Adenocarcinoma
Gaoming Wang, Ludi Yang, Miao Hu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top